Multinucleated osteoclast formation in vivo and in vitro by P2X7 receptor-deficient mice

被引:59
作者
Gartland, A
Buckley, KA
Hipskind, RA
Perry, MJ
Tobias, JH
Buell, G
Chessell, I
Bowler, WB
Gallagher, JA
机构
[1] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA
[2] Univ Liverpool, Human Bone Cell Res Grp, Dept Human Anat & Cell Biol, Liverpool L69 3GE, Merseyside, England
[3] Inst Genet Mol Montpellier, UMR 5535 CNRS, F-34293 Montpellier, France
[4] Univ Bristol, Sch Vet, Dept Anat, Bristol BS2 8EJ, Avon, England
[5] Univ Bristol, Bristol Royal Infirm, Rheumatol Unit, Bristol BS2 8HW, Avon, England
[6] Serono, CH-1211 Geneva, Switzerland
[7] Glaxo Wellcome Inc, Neurol & Rheumatol Syst, Stevenage SG1 2NY, Herts, England
[8] Strakan Pharmaceut, Buckholm Mill TD1 2HB, Galashiels, England
来源
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION | 2003年 / 13卷 / 2-4期
关键词
P2; receptor; osteoclasts; skeletal effects; cell fusion;
D O I
10.1615/CritRevEukaryotGeneExpr.v13.i24.150
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
: The P2X(7) receptor is a member of the family of P2X purinergic receptors, which upon sustained activation forms large pores in the plasma membrane. In cells of hematopoietic origin, P2X(7) receptor activation has been shown to lead to multiple downstream events, including cytokine release, cell permeabilization, and apoptosis. This receptor has also been implicated in the generation of multinucleated giant cells, polykaryons, and osteoclasts. We have recently demonstrated that a blockade of this receptor inhibits osteoclast formation in vitro; therefore, we examined mice deficient in the P2X(7) receptor in the context of bone. These mice were healthy and displayed no overt skeletal problems. Furthermore, we were able to demonstrate their ability to form multinucleated cells, in particular osteoclasts, both in vivo and in vitro. We also demonstrate the ability of P2X(7)R(-/-) multinucleated osteoclasts, upon stimulation with maitotoxin (MTX), to form pores in the plasma membrane in vitro. These findings are consistent with the existence of an endogenous pore structure present in osteoclast precursor cells that can be activated either by the P2X(7) receptor, or in its absence, by alternative signals to mediate fusion and pore formation. These data provide further insight into the mode of action of the P2X(7) receptor.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 41 条
[31]   Postnatal and pubertal skeletal changes contribute predominantly to the differences in peak bone density between C3H/HeJ and C57BL/6J mice [J].
Richman, C ;
Kutilek, S ;
Miyakoshi, N ;
Srivastava, AK ;
Beamer, WG ;
Donahue, LR ;
Rosen, CJ ;
Wergedal, JE ;
Baylink, DJ ;
Mohan, S .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (02) :386-397
[32]   Maitotoxin activates a nonselective cation channel and a P2Z/P2X7-like cytolytic pore in human skin fibroblasts [J].
Schilling, WP ;
Sinkins, WG ;
Estacion, M .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 277 (04) :C755-C765
[33]   Maitotoxin and P2Z/P2X7 purinergic receptor stimulation activate a common cytolytic pore [J].
Schilling, WP ;
Wasylyna, T ;
Dubyak, GR ;
Humphreys, BD ;
Sinkins, WG .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 277 (04) :C766-C776
[34]  
SCHULZELOHOFF E, 1998, AM J PHYSIOL, V275, pF692
[35]   Histomorphometric studies show that bone formation and bone mineral apposition rates are greater in C3H/HeJ (high-density) than C57BL/6J (low-density) mice during growth [J].
Sheng, MHC ;
Baylink, DJ ;
Beamer, WG ;
Donahue, LR ;
Rosen, CJ ;
Lau, KHW ;
Wergedal, JE .
BONE, 1999, 25 (04) :421-429
[36]   Altered cytokine production in mice lacking P2X7 receptors [J].
Solle, M ;
Labasi, J ;
Perregaux, DG ;
Stam, E ;
Petrushova, N ;
Koller, BH ;
Griffiths, RJ ;
Gabel, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) :125-132
[37]   P2-mediated responses in osteoclasts and osteoclast-like cells [J].
Steinberg, TH ;
Jorgensen, NR ;
Bong, JS ;
Henriksen, Z ;
Atal, N ;
Lin, GC ;
Bennett, BD ;
Eriksen, EF ;
Sorensen, OH ;
Civitelli, R .
DRUG DEVELOPMENT RESEARCH, 2001, 53 (2-3) :126-129
[38]  
STEINBERG TH, 1987, J BIOL CHEM, V262, P8884
[39]   The cytolytic P-2Z receptor for extracellular ATP identified as a P-2X receptor (P2X(7)) [J].
Surprenant, A ;
Rassendren, F ;
Kawashima, E ;
North, RA ;
Buell, G .
SCIENCE, 1996, 272 (5262) :735-738
[40]   Hetero-oligomeric assembly of P2X receptor subunits - Specificities exist with regard to possible partners [J].
Torres, GE ;
Egan, TM ;
Voigt, MM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6653-6659